Maintained by Sreepriya Prasannan

MSc Digital Transformation of Life Sciences (Innopharma Education / Griffith College); MSc & BSc Botany HSE Spark Ignite 2026 — Top 14 finalist

Compiled from ClinicalTrials.gov and CTIS registry records · Last verified 26 Sep 2026 · Editorial standards

At a glance

The Fourth Affiliated Hospital of Zhejiang University School of Medicine is the lead sponsor of 43 current clinical trials in our China register. 31 are recruiting patients now. The most common phase is Not applicable. The drugs named most often in its trials are Adebrelimab, Bevacizumab and Capecitabine. The most-studied condition is Lung Cancer.

ClinicalTrials.gov trials by status

Recruiting3172%
Not yet open716%
Active, closed37%
By invitation25%

Trials by phase

Not applicable2456%
Observational819%
Phase 4512%
Phase 1/237%
Phase 225%
Phase 112%

Clinical trials sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine

43 on ClinicalTrials.gov

Study	Phase	Status	Start	Registers
Effect of Different Cold Therapy Programs in Patients Received Total Knee Arthroplasty Operation NCT07021287 · ClinicalTrials.gov ↗ · Total Knee Arthroplasty	Not applicable	Recruiting	2024-07	China
Bone Management in Pregnancy Outcomes in Epilepsy NCT07651709 · ClinicalTrials.gov ↗ · Epilepsy, Pregnant Woman, Bone Health Drug: Vitamin D	Not applicable	Recruiting	2026-06	China
Effect of Electronic Moxibustion Apparatus on Pain Degree and Wound Healing of Patients After Craniocerebral Surgery NCT06534710 · ClinicalTrials.gov ↗ · Patients Undergoing Craniocerebral Surgery	Not applicable	Recruiting	2024-09	China
Analysis of the Microenvironment of Lung Cancer and Exploration of the Mechanism of Resistance to Immunotherapy NCT05636605 · ClinicalTrials.gov ↗ · Lung Cancer	Observational	Recruiting	2018-01	China
Efficacy and Safety of Oliceridine for Moderate to Severe Acute Pain After Orthopedic Surgery NCT06320041 · ClinicalTrials.gov ↗ · Postoperative Pain	Phase 4	Recruiting	2024-08	China
A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Symptoms After Enucleation of the Prostate NCT07357324 · ClinicalTrials.gov ↗ · Benign Prostatic Hyperplasia, Nocturia Associated With Nocturnal Polyuria	Phase 4	Recruiting	2024-12	China
A Randomized Controlled Study on the Effect of MRJPs on Improving Ovarian Function and Endometrial Receptivity NCT07246733 · ClinicalTrials.gov ↗ · Diminished Ovarian Reserve (DOR), Thin Endometrium	Not applicable	Recruiting	2025-07	China
The Clinical Effect of Sugammadex Sodium (Domestic) for Antagonizing Neuromuscular Blockade After Thoracic Surgery NCT06334562 · ClinicalTrials.gov ↗ · Neuromuscular Blockade Drug: Neostigmine	Not applicable	Recruiting	2024-06	China
The Influence of Systematic Psychological Intervention on Patients About VSD Drainage Surgery NCT06424561 · ClinicalTrials.gov ↗ · Chronic Wounds	Not applicable	Recruiting	2024-12	China
Application of Platelet-rich Plasma (PRP) in Reproductive Medicine NCT06645379 · ClinicalTrials.gov ↗ · Premature Ovarian Insufficiency, Intrauterine Adhesion, Poor Ovarian Response	Not applicable	Recruiting	2024-10	China
Clinical Study on the Therapeutic Efficacy of Biportal Endoscopic Decompression Spine Surgery and Lumbar Decompression Fusion Surgery in the Treatment of Degenerative Lumbar Spondylolisthesis NCT07289737 · ClinicalTrials.gov ↗ · Lumbar Degenerative Spondylolisthesis	Observational	Recruiting	2025-12	China
Efficacy and Safety of Chemotherapy With XELOX (Oxaliplatin + Capecitabine) and Bevacizumab in Combination With Adebrelimab in First-line Treatment of Microsatellite Stable (MSS) Initially Unresectable Metastatic Colorectal Cancer NCT06282445 · ClinicalTrials.gov ↗ · Colorectal Cancer Metastatic Drugs: Adebrelimab, Bevacizumab, Capecitabine	Phase 2	Recruiting	2024-03	China
Research and Application of an AI Agent-Based MBBS Course Assistant NCT07752160 · ClinicalTrials.gov ↗ · an Intelligent Teaching Agent for the "Epidemiology" Course of the MBBS Program, Students' Critical Thinking, Practical Ability and Learning Outcomes	Not applicable	Recruiting	2026-05	China
Effect of Anti-inflammatory Diet in Patients With Inflammatory Bowel Disease NCT06342011 · ClinicalTrials.gov ↗ · Inflammatory Bowel Diseases	Not applicable	Recruiting	2024-04	China
A Randomized Controlled Trial to Evaluate the Effectiveness of Bleomycin and Cryotherapy in Treating Plantar Warts. NCT06718192 · ClinicalTrials.gov ↗ · Verruca Plantaris	Phase 1/2	Recruiting	2024-12	China
A Study on the Effect of Electronic Moxibustion Based on Ziwu Liuzhu in Treating Constipation in Stroke Patients NCT07372326 · ClinicalTrials.gov ↗ · Stroke Patients With Constipation	Not applicable	Recruiting	2025-05	China
Investigation Into the Dynamic Variations of End-Tidal Carbon Monoxide Concentration (ETCOc) in Neonates Utilizing Non-Dispersive Infrared Spectroscopy and Its Implications for Jaundice Management NCT07346976 · ClinicalTrials.gov ↗ · Neonatal Hyperbilirubinemia	Not applicable	Recruiting	2025-12	China
Keloid Pathogenesis And Fibroblast Activation Study NCT07682636 · ClinicalTrials.gov ↗ · Keloids, Fibroblast	Observational	Recruiting	2025-05	China
Tenofovir Disoproxil Fumarate in the Treatment of Parkinson's Disease NCT06356662 · ClinicalTrials.gov ↗ · Parkinson Disease Drug: Tenofovir Disoproxil Fumarate	Phase 1	Recruiting	2024-01	China
Evaluation System for Lecanemab Efficacy Using Gold Electrode ECL to Monitor Alzheimer's Biomarkers NCT07688460 · ClinicalTrials.gov ↗ · Alzheimer Disease Drug: Lecanemab	Phase 4	Recruiting	2026-07	China
miR-342-5p/AnkG Pathway in Early AD Synaptic Dysfunction NCT07353502 · ClinicalTrials.gov ↗ · Alzheimer Disease, Biomarker in Early Diagnosis	Not applicable	Recruiting	2025-06	China
The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea NCT07343635 · ClinicalTrials.gov ↗ · Erythematotelangiectatic Rosacea Drugs: Doxycycline, Hydroxychloroquine, Tofacitinib	Not applicable	Recruiting	2026-02	China
Effects of Myoelectric Biofeedback on Upper Limb Function in Post-stroke Patients NCT06443008 · ClinicalTrials.gov ↗ · Biofeedback, Rehabilitation, Cerebral Infarction	Not applicable	Recruiting	2024-07	China
A Dose Escalation and Dose Expansion Clinical Study of STI-7349 in Subjects With Advanced Solid Tumors NCT05978102 · ClinicalTrials.gov ↗ · Advanced Solid Tumor Drug: Pembrolizumab	Phase 1/2	Recruiting	2023-08	China
Application and Effect of "Internet + Nursing" in Hip Fragility Fracture Patients Based on Fracture Liaison Service NCT06975254 · ClinicalTrials.gov ↗ · Fragility Fractures	Not applicable	Recruiting	2025-04	China
Research on Building and Application of Internet-based Home Pre-rehabilitation Model for Lung Surgery Patients. NCT06458894 · ClinicalTrials.gov ↗ · Lung Cancer	Not applicable	Recruiting	2024-08	China
Randomized Controlled Trial of Berberine in Combination With Doxycycline in the Treatment of Chronic Endometritis NCT07180563 · ClinicalTrials.gov ↗ · Chronic Endometritis	Phase 1/2	Recruiting	2025-03	China
A Stuty on the Treatment and Nursing Care of CIPN Patients With Traditional Chinese Medicine Hot Package NCT06492083 · ClinicalTrials.gov ↗ · Chemotherapy	Not applicable	Recruiting	2024-10	China
Study on the Preventive Effect of Establishing an Integrated Working Group of Doctors and Nurses in Operating Room NCT06579599 · ClinicalTrials.gov ↗ · Orthopedic Disorder, Incision Infection	Not applicable	Recruiting	2024-12	China
The Clinical Application of Ultramicro-flow Technique in the Treatment of Benign Uterine Tumors With High-intensity Focused Ultrasound NCT06435663 · ClinicalTrials.gov ↗ · Patients With Uterine Fibroids Receiving HIFUA Treatment ,and Can Undergo Regular Follow-up	Not applicable	Recruiting	2024-12	China
The Preventive and Therapeutic Effects of Spirulina Preparations on Ulcers of Oral Mucosa NCT07723612 · ClinicalTrials.gov ↗ · Recurrent Aphthous Stomatitis, Mouth Ulcer	Not applicable	Recruiting	2026-06	China
Efficacy and Safety of SKB264 Plus Anlotinib in EGFR-TKI-Resistant Advanced NSCLC With Liver Metastasis NCT07545213 · ClinicalTrials.gov ↗ · Non-small Cell Lung Cancer, EGFR Mutant Advanced Non-small Cell Lung Cancer Drug: Sacituzumab tirumotecan	Phase 2	Not yet open	2026-04	China
Research on the Impact of Chronic Pelvic Pain on Endometriosis NCT06584760 · ClinicalTrials.gov ↗ · Chronic Pelvic Pain, Endometriosis	Observational	Not yet open	2024-09	China
The Application of Kinesio Taping Technique in the Early Upper Limb Functional Activities Induction of Hemiplegic Patients After Stroke NCT06834750 · ClinicalTrials.gov ↗ · Cerebral Infarction Recovery, Rehabilitation Treatment, Upper Extremity Motor Function	Not applicable	Not yet open	2025-04	China
A Study on the Effectiveness of Rest Shame Interventions Based on Cognitive Behavioural Therapy in Reducing Social Media Addiction NCT07284160 · ClinicalTrials.gov ↗ · Rest is Shameful	Not applicable	Not yet open	2026-01	China
The Study on the Effect of Different Administration Methods of Simethicone in Reducing Bubbles During Bowel Preparation NCT06919120 · ClinicalTrials.gov ↗ · Colonoscopy	Phase 4	Not yet open	2025-06	China
A Prospective, Single-centre, Observational Cohort Study on the Efficacy and Safety of Bacterial Lysate (OM-85) in Combination With Antihistamines for the Treatment of Chronic Spontaneous Urticaria (CSU) NCT07557888 · ClinicalTrials.gov ↗ · Chronic Spontaneous Urticaria (CSU)	Observational	Not yet open	2026-05	China
The Clinical Research of Traditional Chinese Medicine Compound Formulas NCT07153731 · ClinicalTrials.gov ↗ · Urologic Injuries, Urology	Phase 4	Not yet open	2025-10	China
Artificial Intelligence in Detecting Cardiac Function NCT06444425 · ClinicalTrials.gov ↗ · Heart Failure, Deep Learning	Observational	By invitation	2024-06	China
Nurse-Led Staged Art Therapy Effects on Psychological Distress and Pregnancy Outcomes in AIH: RCT NCT07356830 · ClinicalTrials.gov ↗ · Music Therapy	Not applicable	By invitation	2025-08	China
Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma NCT06966986 · ClinicalTrials.gov ↗ · Liver Carcinoma	Observational	Active, closed	2024-09	China
Effect of Bagua Auriculotherapy on Pain in Patients Undergoing Hysteroscopy NCT07512791 · ClinicalTrials.gov ↗ · Procedural Pain	Not applicable	Active, closed	2026-03	China
Combined Statin and PD-1/PD-L1 Inhibitors in Treating Non-small Cell Lung Cancer NCT05636592 · ClinicalTrials.gov ↗ · Lung Cancer	Observational	Active, closed	2022-10	China

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

Drugs in The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials

13 compounds

Drugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.

Adebrelimab1 Bevacizumab1 Capecitabine1 Doxycycline1 Hydroxychloroquine1 Lecanemab1 Neostigmine1 Oxaliplatin1 Pembrolizumab1 Sacituzumab tirumotecan1 Tenofovir Disoproxil Fumarate1 Tofacitinib1 Vitamin D1

Conditions in The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials

61 conditions

Lung Cancer3 Alzheimer Disease2Total Knee Arthroplasty1Non-small Cell Lung Cancer1EGFR Mutant Advanced Non-small Cell Lung Cancer1Liver Carcinoma1Epilepsy1Pregnant Woman1Bone Health1Patients Undergoing Craniocerebral Surgery1Postoperative Pain1 Heart Failure1 Deep Learning1 Benign Prostatic Hyperplasia1Nocturia Associated With Nocturnal Polyuria1Diminished Ovarian Reserve (DOR)1Thin Endometrium1Chronic Pelvic Pain1Endometriosis1Neuromuscular Blockade1Cerebral Infarction Recovery1Rehabilitation Treatment1Upper Extremity Motor Function1Emg Biofeedback1

By trial register

Register	Trials	Recruiting
Clinical trials in China	43	31

A trial with sites in more than one country appears in each of those registers.

Other sponsors in Lung Cancer

Sponsor	Trials
Second Affiliated Hospital of Guangzhou Medical University	10
Shanghai Chest Hospital	9
Shanghai Pulmonary Hospital, Shanghai, China	8
The First Affiliated Hospital of Guangzhou Medical University	6
Intuitive Surgical	4
Guangdong Provincial People's Hospital	3
All India Institute of Medical Sciences	2
Liu Huang	2
Zhou Chengzhi	2
Queen's University, Belfast	1

Sponsors with the most current trials registered for this condition.

Questions about The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials

How many clinical trials does The Fourth Affiliated Hospital of Zhejiang University School of Medicine sponsor?

The Fourth Affiliated Hospital of Zhejiang University School of Medicine is the lead sponsor of 43 current trials on ClinicalTrials.gov in our China register, as of the registry sync on 26 September 2026. Completed and withdrawn studies are not counted.

Are The Fourth Affiliated Hospital of Zhejiang University School of Medicine trials recruiting?

Yes. 31 of its 43 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Which drugs is The Fourth Affiliated Hospital of Zhejiang University School of Medicine testing?

Its current trials name 13 drugs and biologicals as interventions. The most frequent are Adebrelimab (1), Bevacizumab (1), Capecitabine (1), Doxycycline (1) and Hydroxychloroquine (1). The number in brackets is how many of its trials name each drug.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 26 Sep 2026.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.

The Fourth Affiliated Hospital of Zhejiang University School of Medicine clinical trials